This is one of those "trying to get my head around something" posts.
Pros
* It's open access
* Uses CC-BY
* no perceived importance criteria
Cons
* It's too expensive. The APC is of $1495 and no option for waivers
+PeerJ has shown it can be done for less. If you need to charge more you are either doing it wrong or you are too greedy.
* Because of this, I wouldn't publish there. Anything bio-related would go to +PeerJ and the very few papers that aren't would to to PLoS ONE, usually with a full or partial APC waiver (unless it is directly related to an active grant).
* Why should I work for Macmillan?
On the face of it, I should decline the invitation. Comments, as always, welcome.
This work is licensed under a Creative Commons Attribution 4.0
Pros
* It's open access
* Uses CC-BY
* no perceived importance criteria
Cons
* It's too expensive. The APC is of $1495 and no option for waivers
+PeerJ has shown it can be done for less. If you need to charge more you are either doing it wrong or you are too greedy.
* Because of this, I wouldn't publish there. Anything bio-related would go to +PeerJ and the very few papers that aren't would to to PLoS ONE, usually with a full or partial APC waiver (unless it is directly related to an active grant).
* Why should I work for Macmillan?
On the face of it, I should decline the invitation. Comments, as always, welcome.
This work is licensed under a Creative Commons Attribution 4.0
No comments:
Post a Comment